Isoliquiritigenin Inhibits the Growth of Prostate Cancer-Reference-Cited by-同舟云学术

Isoliquiritigenin Inhibits the Growth of Prostate Cancer

Published:2003-05 Issue:5 Volume:43 Page:580-586
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Kanazawa Motohiro,Satomi Yoshiko,Mizutani Yoichi,Ukimura Osamu,Kawauchi Akihiro,Sakai Toshiyuki,Baba Masaki,Okuyama Toru,Nishino Hoyoku,Miki Tsuneharu

Publisher

Elsevier BV

Subject

Urology

Reference27 articles.

1. Longitudinal gompertzian analysis of mortality from prostate cancer in Japan, 1955–1996;Imaizumi;Cancer Detect. Prev.,2000

2. Cancer statistics, 1998;Landis;CA Cancer J. Clin.,1998

3. The treatment of prostate cancer: an overview of current options;Pirtskhalaishvili;Cancer Pract.,2001

4. Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer;DiPaola;New Engl. J. Med.,1998

5. Prospective trial of the herbal supplement PC-SPES in patients with progressive prostate cancer;Small;J. Clin. Oncol.,2000

Cited by 148 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis and apoptotic activity of substituted chalcones tethered 1,3,5-triazine hybrids: An insights from molecular docking, molecular dynamics simulations, DFT, ADME, and DAPI analyses;Journal of Molecular Structure;2024-11

2. Significance of Chalcone Scaffolds in Medicinal Chemistry;Topics in Current Chemistry;2024-06-27

3. Role of Medicinal Plants Against Cancer;Advances in Medical Diagnosis, Treatment, and Care;2024-04-19

4. Effect, main targets and molecular mechanisms of glycyrrhiza-derived flavonoids on malignant tumor in comprehensive cancer treatment;Tropical Journal of Pharmaceutical Research;2024-02-05

5. Isoliquiritigenin, a potential therapeutic agent for treatment of inflammation-associated diseases;Journal of Ethnopharmacology;2024-01